Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,116Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Acme Lifetech

02 1Aeron Remedies

03 4Aurobindo Pharma Limited

04 2Caristar Laboratories

05 2Delius Pharmaceuticals

06 2Dycine Pharma

07 1Halewood Laboratories Pvt. Ltd

08 1Hanlim Pharmaceuticals Inc

09 3LAB.GUIDOTTI SpA

10 1Myungmoon Pharm. Co., LTD.

11 5PTC Therapeutics

12 4Sun Pharmaceutical Industries Limited

13 2Swasthya Healthcare

14 3TEOFARMA Srl

15 1Themis Medicare

16 1Tris Pharma Inc

17 1Unicor Pharmatech

18 4Upsher-Smith Laboratories

19 1Vaishali Pharma Ltd

20 1Vega Biotech Pvt. Ltd.

21 5ZRS LABS

22 1Zota Healthcare Ltd

23 4Zydus Lifesciences

24 26Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

02

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

03

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2017-02-09

Application Number : 208685

Regulatory Info : RX

Registration Country : USA

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

11

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

12

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

13

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

14

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2024-04-25

Application Number : 217813

Regulatory Info : RX

Registration Country : USA

blank

15

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

16

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

17

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

18

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

19

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : JAYTHARI

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-04-08

Application Number : 219254

Regulatory Info : RX

Registration Country : USA

blank

20

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

DEFLAZACORT

Brand Name : JAYTHARI

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-04-08

Application Number : 219254

Regulatory Info : RX

Registration Country : USA

blank